drugset / Trial / NCT01286571

Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food

NCT01286571 ↗

Phase 1 Completed 14 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to investigate the effect of food on the relative bioavailability of a 50 mg BI 135585 XX tablet.

Timeline

Start
2011-01
Primary completion
2011-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 135585 Unknown 50 mg Oral

Indications

No indication recorded.